Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,026.00
Bid: 12,024.00
Ask: 12,026.00
Change: 38.00 (0.32%)
Spread: 2.00 (0.017%)
Open: 12,254.00
High: 12,256.00
Low: 12,020.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

A COVID-19 shot for $150? Online scams surge as slow vaccine rollout frustrates

Tue, 05th Jan 2021 12:00

By Tina Bellon

NEW YORK, Jan 5 (Reuters) - As millions of people await
their turn to get a COVID-19 vaccine that could be months away,
scammers online, in emails and on messaging apps are luring
victims with claims they can deliver shots within days for as
little as $150.

COVID-19 vaccine scams are on the rise, according to
European and U.S. government officials who are warning the
public of fraudsters out for money and personal data.

A Reuters search online, in dark web forums and on messaging
app Telegram found seven different offers for alleged COVID-19
vaccines.

Scams include emails promising entry to supposedly secret
lists for early vaccine access and robocallers impersonating
government agencies. Message boards on the so-called dark web
have added COVID-19 vaccines to more traditional illicit goods
for sale.

The U.S. FBI and Interpol, among others, have warned of
emerging pandemic-related fraud schemes, saying false cures and
vaccines advertised on fake websites could pose cyber threats
and a significant risk to peoples' health, or even lives.

Website domains containing the word vaccine in combination
with COVID-19 or coronavirus more than doubled since October to
roughly 2,500 in November, when the first legitimate vaccines
were nearing regulatory approval, according to cybersecurity
firm Recorded Future, which is tracking COVID-19 fraud online.

"So far a lot of these domains just appear to be
opportunistic registrations, but some are going to be used for
phishing attempts to have people click on (malicious) links,"
said Lindsay Kaye, director of operational outcomes at Recorded
Future.

Kaye said her team, which also scours the dark web, so far
has not come across any legitimate vaccine diverted from
healthcare facilities or national stockpiles.

The scams are preying on concerns about the far
slower-than-promised rollout of vaccines to protect against the
virus that has claimed more than 1.8 million lives worldwide so
far. Most people will likely have to wait well into the spring,
or even summer, to get their shot.

In the United States, only about 4.5 million people had
received their first shot as of Monday, the U.S. Centers for
Disease Control and Prevention reported. That is a fraction of
the 20 million who were supposed to have been vaccinated by the
end of 2020, according to earlier government forecasts.

VACCINES, GUNS AND MONEY

On dark web forum Agartha, fake COVID-19 vaccines were
offered next to cocaine, opioid medication, "super high quality
fake money," hand guns and gift cards. Posts showed stock photos
of vaccines and offered vials for $500 and $1,000, or the
equivalent in Bitcoin.

On another dark web site, a seller claiming to be from the
"Wuhan Institute of Science" offered COVID-19 vaccines in
exchange for a donation, and asked buyers to provide their
medical history.

On Telegram, several channels claimed to offer COVID-19
vaccines, accompanied by stock images. One user offered supposed
Moderna Inc vaccines for $180, and claimed the vaccine
from Pfizer Inc and BioNTech SE could be had
for $150 and AstraZeneca's for $110 per vial.

Asked how the vaccines would be shipped, the account creator
said they were transported in "regulated temperature packs" and
ice packs within a few days, or overnight for an additional
charge.

Actual COVID-19 vaccines, particularly the Pfizer/BioNTech
offering, must be temperature controlled to remain effective,
with drugmakers equipping shipments with temperature trackers to
ensure the cold chain. Vaccine shipments and distribution are
also tightly controlled by officials and will be administered
at no cost.

The United States has so far authorized two COVID-19
vaccines for emergency use - the ones from Pfizer/BioNTech and
Moderna. The European Union to date has authorized the
Pfizer/BioNTech vaccine and is expected to clear the Moderna
vaccine this week.

The UK has already authorized those two and just added the
vaccine developed by Oxford University with AstraZeneca.

Asked about vaccine scams, Pfizer said it had taken
meticulous steps to reduce the risk of counterfeiting and
tracked trends very carefully.

"Patients should never try to secure a vaccine online - no
legitimate vaccine is sold online - and only get vaccinated at
certified vaccination centers or by certified healthcare
providers," a Pfizer spokesman said in a statement.

Moderna referred a request for comment to the U.S.
Department of Health and Human Services (HHS), which did not
respond. AstraZeneca did not respond to a request for comment.

The HHS, FBI and U.S. Department of Justice have urged the
public to report any COVID-19 vaccine scams, including people
asking for out-of-pocket payments for the vaccine and online
vaccine advertisements.

(Reporting by Tina Bellon in New York
Editing by Bill Berkrot)

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.